SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Xiaotong Fan, Brian D. Nelson, Yi Ai, David K. Stiles, Don M. Gash, Peter A. Hardy, Zhiming Zhang, Continuous intraputamenal convection-enhanced delivery in adult rhesus macaques, Journal of Neurosurgery, 2015, 1

    CrossRef

  2. 2
    Juliann D. Jaumotte, Michael J. Zigmond, Comparison of GDF5 and GDNF as neuroprotective factors for postnatal dopamine neurons in ventral mesencephalic cultures, Journal of Neuroscience Research, 2014, 92, 11
  3. 3
    X.T. Fan, F. Zhao, Y. Ai, A. Andersen, P. Hardy, F. Ling, G.A. Gerhardt, Z. Zhang, J.E. Quintero, Cortical glutamate levels decrease in a non-human primate model of dopamine deficiency, Brain Research, 2014, 1552, 34

    CrossRef

  4. 4
    Raymond T. Bartus, Tiffany L. Baumann, Lamar Brown, Brian R. Kruegel, Jeffrey M. Ostrove, Christopher D. Herzog, Advancing neurotrophic factors as treatments for age-related neurodegenerative diseases: developing and demonstrating “clinical proof-of-concept” for AAV-neurturin (CERE-120) in Parkinson's disease, Neurobiology of Aging, 2013, 34, 1, 35

    CrossRef

  5. 5
    Jeffrey H. Kordower, Anders Bjorklund, Trophic Factor Gene Therapy for Parkinson's Disease, Movement Disorders, 2013, 28, 1
  6. 6
    Raymond T. Bartus, Translating the therapeutic potential of neurotrophic factors to clinical ‘proof of concept’: A personal saga achieving a career-long quest, Neurobiology of Disease, 2012, 48, 2, 153

    CrossRef

  7. 7
    Dustin R. Wakeman, Hemraj B. Dodiya, Jeffrey H. Kordower, Cell Transplantation and Gene Therapy in Parkinson's Disease, Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2011, 78, 1
  8. 8
    K. Stahl, M.N. Mylonakou, Ø. Skare, M. Amiry-Moghaddam, R. Torp, Cytoprotective effects of growth factors: BDNF more potent than GDNF in an organotypic culture model of Parkinson's disease, Brain Research, 2011, 1378, 105

    CrossRef

  9. 9
    Fernando Alonso-Frech, Juan Juni Sanahuja, Amelia Mendoza Rodriguez, Exercise and Physical Therapy in Early Management of Parkinson Disease, The Neurologist, 2011, 17, S47

    CrossRef

  10. 10
    Ann-Charlotte Granholm, Vandana Zaman, Jennifer Godbee, Michael Smith, Riad Ramadan, Claudia Umphlet, Patrick Randall, Narayan R. Bhat, Baerbel Rohrer, Lawrence D. Middaugh, Heather A. Boger, Prenatal LPS increases Inflammation in the Substantia Nigra of Gdnf Heterozygous Mice, Brain Pathology, 2011, 21, 3
  11. 11
    Raymond T. Bartus, Lamar Brown, Alistair Wilson, Brian Kruegel, Joao Siffert, Eugene M. Johnson, Jeffrey H. Kordower, Christopher D. Herzog, Properly scaled and targeted AAV2-NRTN (neurturin) to the substantia nigra is safe, effective and causes no weight loss: Support for nigral targeting in Parkinson's disease, Neurobiology of Disease, 2011, 44, 1, 38

    CrossRef

  12. 12
    Tomas Bjorklund, Jeffrey H. Kordower, Gene therapy for Parkinson's disease, Movement Disorders, 2010, 25, S1
  13. 13
    Suresh Babu Rangasamy, Katherine Soderstrom, Roy A.E. Bakay, Jeffrey H. Kordower, Recent Advances in Parkinson’S Disease - Translational and Clinical Research, 2010,

    CrossRef

  14. 14
    Fredric P Manfredsson, Nihal Tumer, Benedek Erdos, Tessa Landa, Christopher S Broxson, Layla F Sullivan, Aaron C Rising, Kevin D Foust, Yi Zhang, Nicholas Muzyczka, Oleg S Gorbatyuk, Philip J Scarpace, Ronald J Mandel, Nigrostriatal rAAV-mediated GDNF Overexpression Induces Robust Weight Loss in a Rat Model of Age-related Obesity, Molecular Therapy, 2009, 17, 6, 980

    CrossRef

  15. 15
    Michael J. Zigmond, Judy L. Cameron, Rehana K. Leak, Karoly Mirnics, Vivienne A. Russell, Richard J. Smeyne, Amanda D. Smith, Triggering endogenous neuroprotective processes through exercise in models of dopamine deficiency, Parkinsonism & Related Disorders, 2009, 15, S42

    CrossRef

  16. 16
    Feng Ding, Liming Luan, Yi Ai, Ashley Walton, Greg A. Gerhardt, Don M. Gash, Richard Grondin, Zhiming Zhang, Development of a stable, early stage unilateral model of Parkinson's disease in middle-aged rhesus monkeys, Experimental Neurology, 2008, 212, 2, 431

    CrossRef

  17. 17
    Tao Xin, Yi Ai, Greg Gerhardt, Don Gash, Zhiming Zhang, Globus pallidus plays a critical role in neurotrophic factor induced functional improvements in hemiparkinsonian monkeys, Biochemical and Biophysical Research Communications, 2008, 370, 3, 434

    CrossRef

  18. 18
    Amie L. Peterson, John G. Nutt, Treatment of Parkinson’s disease with trophic factors, Neurotherapeutics, 2008, 5, 2, 270

    CrossRef

  19. 19
    Raymond T. Bartus, Christopher D. Herzog, Kathie Bishop, Jeffrey M. Ostrove, Mark Tuszynski, Jeffrey H. Kordower, Mehdi Gasmi, Issues regarding gene therapy products for Parkinson's disease: The development of CERE-120 (AAV-NTN) as one reference point, Parkinsonism & Related Disorders, 2007, 13, S469

    CrossRef

  20. 20
    Christopher D. Herzog, Biplob Dass, James E. Holden, James Stansell, Mehdi Gasmi, Mark H. Tuszynski, Raymond T. Bartus, Jeffrey H. Kordower, Striatal delivery of CERE-120, an AAV2 vector encoding human neurturin, enhances activity of the dopaminergic nigrostriatal system in aged monkeys, Movement Disorders, 2007, 22, 8
  21. 21
    Zhiming Zhang, Anders H. Andersen, Yi Ai, Aaron Loveland, Peter A. Hardy, Greg A. Gerhardt, Don M. Gash, Assessing nigrostriatal dysfunctions by pharmacological MRI in parkinsonian rhesus macaques, NeuroImage, 2006, 33, 2, 636

    CrossRef

  22. 22
    Michael P. Smith, Anita Fletcher-Turner, David M. Yurek, Wayne A. Cass, Calcitriol Protection against Dopamine Loss Induced by Intracerebroventricular Administration of 6-Hydroxydopamine, Neurochemical Research, 2006, 31, 4, 533

    CrossRef

  23. 23
    Nihal Tümer, Philip J. Scarpace, M. Devrim Dogan, Christopher S. Broxson, Michael Matheny, David M. Yurek, Carmen S. Peden, Corinna Burger, Nicholas Muzyczka, Ronald J. Mandel, Hypothalamic rAAV-mediated GDNF gene delivery ameliorates age-related obesity, Neurobiology of Aging, 2006, 27, 3, 459

    CrossRef

  24. 24
    Mikko Airavaara, Jelena Mijatovic, Tanja Vihavainen, Timo Petteri Piepponen, Mart Saarma, Liisa Ahtee, In heterozygous GDNF knockout mice the response of striatal dopaminergic system to acute morphine is altered, Synapse, 2006, 59, 6
  25. 25
    Mei Sun, Lingxin Kong, Xiaodan Wang, Xiu-gui Lu, Qingsheng Gao, Alfred I. Geller, Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease, Brain Research, 2005, 1052, 2, 119

    CrossRef

  26. 26
    Pedro Barroso-Chinea, Ignacio Cruz-Muros, María S. Aymerich, Manuel Rodríguez-Díaz, Domingo Afonso-Oramas, José L. Lanciego, Tomás González-Hernández, Striatal expression of GDNF and differential vulnerability of midbrain dopaminergic cells, European Journal of Neuroscience, 2005, 21, 7
  27. 27
    Christina L Zuch, Daniel David, Livia Ujhelyi, John L Hudson, Greg A Gerhardt, Paul L Kaplan, Paula C Bickford, Beneficial effects of intraventricularly administered BMP-7 following a striatal 6-hydroxydopamine lesion, Brain Research, 2004, 1010, 1-2, 10

    CrossRef

  28. 28
    A. Sarabi, B.J. Hoffer, L. Olson, M. Morales, Glial cell line neurotrophic factor-family receptor α-1 is present in central neurons with distinct phenotypes, Neuroscience, 2003, 116, 1, 261

    CrossRef

  29. 29
    Yi Ai, William Markesbery, Zhiming Zhang, Richard Grondin, Dennis Elseberry, Greg A. Gerhardt, Don M. Gash, Intraputamenal infusion of GDNF in aged rhesus monkeys: Distribution and dopaminergic effects, Journal of Comparative Neurology, 2003, 461, 2
  30. 30
    Hengyi Xiao, Yoko Hirata,,, Ken-ichi Isobe, Kazutoshi Kiuchi, Glial cell line-derived neurotrophic factor up-regulates the expression of tyrosine hydroxylase gene in human neuroblastoma cell lines, Journal of Neurochemistry, 2002, 82, 4
  31. 31
    Jodi L. McBride, Jeffrey H. Kordower, Plasticity in the Adult Brain: From Genes to Neurotherapy, 2002,

    CrossRef

  32. 32
    Mahmoud M. Iravani, Sergio Costa, Michael J. Jackson, Banu C. Tel, Carla Cannizzaro, Ronald K. B. Pearce, Peter Jenner, GDNF reverses priming for dyskinesia in MPTP-treated, l-DOPA-primed common marmosets, European Journal of Neuroscience, 2001, 13, 3
  33. 33
    Zhiming Zhang, Anders H. Andersen, Malcolm J. Avison, Greg A. Gerhardt, Don M. Gash, Functional MRI of apomorphine activation of the basal ganglia in awake rhesus monkeys, Brain Research, 2000, 852, 2, 290

    CrossRef

  34. 34
    Nina Törnqvist, Lars Björklund, Per Almqvist, Lars Wahlberg, Ingrid Strömberg, Implantation of Bioactive Growth Factor-Secreting Rods Enhances Fetal Dopaminergic Graft Survival, Outgrowth Density, and Functional Recovery in a Rat Model of Parkinson's Disease, Experimental Neurology, 2000, 164, 1, 130

    CrossRef

  35. 35
    William P. Melega, Goran Laćan, Antonio A.F. Desalles, Michael E. Phelps, Long-term methamphetamine-induced decreases of [11C]WIN 35,428 binding in striatum are reduced by GDNF: PET studies in the vervet monkey, Synapse, 2000, 35, 4
  36. 36
    Martha C. Bohn, A commentary on glial cell line-derived neurotrophic factor (GDNF), Biochemical Pharmacology, 1999, 57, 2, 135

    CrossRef

  37. 37
    Wayne A Cass, Doriann J Walker, Michael W Manning, Augmented methamphetamine-induced overflow of striatal dopamine 1 day after GDNF administration, Brain Research, 1999, 827, 1-2, 104

    CrossRef

  38. 38
    Michael R. Hoane, Amit G. Gulwadi, Sharon Morrison, Ginny Hovanesian, Mark D. Lindner, Weng Tao, Differential in Vivo Effects of Neurturin and Glial Cell-Line-Derived Neurotrophic Factor, Experimental Neurology, 1999, 160, 1, 235

    CrossRef

  39. 39
    C. W. Olanow, W. G. Tatton, ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE, Annual Review of Neuroscience, 1999, 22, 1, 123

    CrossRef

  40. 40
    Greg A. Gerhardt, Wayne A. Cass, Peter Huettl, Scot Brock, Zhiming Zhang, Don M. Gash, GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys, Brain Research, 1999, 817, 1-2, 163

    CrossRef

  41. 41
    Zhiming Zhang, Ming Zhang, Yi Ai, Calum Avison, Don.M. Gash, MPTP-Induced Pallidal Lesions in Rhesus Monkeys, Experimental Neurology, 1999, 155, 1, 140

    CrossRef

  42. 42
    Meleik A. Hebert, Barry J. Hoffer, Zhiming Zhang, Wayne A. Cass, Alexander F. Hoffman, Don M. Gash, Greg A. Gerhardt, CNS Regeneration, 1999,

    CrossRef

  43. 43
    Erwan Bezard, Christian E Gross, Compensatory mechanisms in experimental and human Parkinsonism: towards a dynamic approach, Progress in Neurobiology, 1998, 55, 2, 93

    CrossRef

  44. 44
    Satoshi Kobayashi, Sven Ove Ögren, Barry J. Hoffer, Lars Olson, Dopamine D1and D2Receptor-Mediated Acute and Long-Lasting Behavioral Effects of Glial Cell Line-Derived Neurotrophic Factor Administered into the Striatum, Experimental Neurology, 1998, 154, 2, 302

    CrossRef

  45. 45
    Judith P. Golden, Robert H. Baloh, Paul T. Kotzbauer, Patricia A. Lampe, Patricia A. Osborne, Jeffrey Milbrandt, Eugene M. Johnson, Expression of neurturin, GDNF, and their receptors in the adult mouse CNS, Journal of Comparative Neurology, 1998, 398, 1
  46. 46
    Douglas G. Walker, Thomas G. Beach, Ren Xu, Jack Lile, Klaus D. Beck, Edith G. McGeer, Patrick L. McGeer, Expression of the proto-oncogene Ret, a component of the GDNF receptor complex, persists in human substantia nigra neurons in Parkinson's disease, Brain Research, 1998, 792, 2, 207

    CrossRef

  47. 47
    Gordon W. Glazner, Xiaojun Mu, Joe E. Springer, Localization of glial cell line-derived neurotrophic factor receptor alpha and c-ret mRNA in rat central nervous system, Journal of Comparative Neurology, 1998, 391, 1
  48. 48
    B Connor, M Dragunow, The role of neuronal growth factors in neurodegenerative disorders of the human brain, Brain Research Reviews, 1998, 27, 1, 1

    CrossRef

  49. 49
    P.A Lapchak, D.M Araujo, D.C Hilt, S Jiao, F Collin, Y Miyoshi, A Yi, Z Zhang, D.M Gash, Topographical distribution of [125I]-glial cell line-derived neurotrophic factor in unlesioned and MPTP-lesioned rhesus monkey brain following a bolus intraventricular injection, Brain Research, 1998, 789, 1, 9

    CrossRef

  50. 50
    Hisanori Kojima, Yasuhiro Abiru, Kenichi Sakajiri, Kazuhiko Watabe, Nobuko Ohishi, Masaharu Takamori, Hiroshi Hatanaka, Kunio Yagi, Adenovirus-Mediated Transduction with Human Glial Cell Line-Derived Neurotrophic Factor Gene Prevents 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Dopamine Depletion in Striatum of Mouse Brain, Biochemical and Biophysical Research Communications, 1997, 238, 2, 569

    CrossRef

  51. 51
    P.A Lapchak, P.J Miller, F Collins, S Jiao, Glial cell line-derived neurotrophic factor attenuates behavioural deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats: comparison of intraventricular and intranigral delivery, Neuroscience, 1997, 78, 1, 61

    CrossRef

  52. 52
    Paul A. Lapchak, Don M. Gash, Shoushu Jiao, Paul J. Miller, Dana Hilt, Glial Cell Line-Derived Neurotrophic Factor: A Novel Therapeutic Approach to Treat Motor Dysfunction in Parkinson's Disease, Experimental Neurology, 1997, 144, 1, 29

    CrossRef

  53. 53
    Yasuyuki Miyoshi, Zhiming Zhang, Aliza Ovadia, Paul A. Lapchak, Frank Collins, Dana Hilt, Carl Lebel, Richard Kryscio, Don M. Gash, Glial cell line–derived neurotrophic factor–levodopa interactions and reduction of side effects in parkinsonian monkeys, Annals of Neurology, 1997, 42, 2
  54. 54
    Paul A. Lapchak, Don M. Gash, F. Collins, Dana Hilt, Paul J. Miller, Dalia M. Araujo, Pharmacological Activities of Glial Cell Line-Derived Neurotrophic Factor (GDNF): Preclinical Development and Application to the Treatment of Parkinson's Disease, Experimental Neurology, 1997, 145, 2, 309

    CrossRef

  55. 55
    Don M. Gash, Greg A. Gerhardt, Barry J. Hoffer, 1997,

    CrossRef

  56. 56
    D. Martin, G. Miller, N. Fischer, D. Dix, T. Cullen, D. Russell, Glial Cell Line-derived Neurotrophic Factor: the Lateral Cerebral Ventricle as a Site of Administration for Stimulation of the Substantia Nigra Dopamine System in Rats, European Journal of Neuroscience, 1996, 8, 6
  57. 57
    Paul A. Lapchak, Therapeutic Potentials for Glial Cell Line-Derived Neurotrophic Factor (GDNF) Based upon Pharmacological Activities in the CNS, Reviews in the Neurosciences, 1996, 7, 3

    CrossRef

  58. 58
    Lars Olson, Toward trophic treatment in parkinsonism: A primate step, Nature Medicine, 1996, 2, 4, 400

    CrossRef